Cisplatin shortage results in substitution of more expensive treatments: Drug cost analysis

被引：0
|
作者：
Lam, Michael [1 ]
Olivier, Timothee
Haslam, Alyson [3 ]
Tuia, Jordan [3 ]
Prasad, Vinay [2 ,3 ,4 ]
机构：
[1] Univ Calif La Jolla, 9500 Gilman Dr, San Diego, CA 92093 USA
[2] Geneva Univ Hosp, Dept Oncol, 4 Gabrielle Perret Gentil St, CH-1205 Geneva, Switzerland
[3] Univ Calif San Francisco, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
[4] Mission Hall Global Hlth Clin Sci Bldg, Dept Epidemiol & Biostat, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 202卷
关键词：
D O I：
10.1016/j.ejca.2024.114019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy
    Kondo, Yu
    Tachi, Tomoya
    Sakakibara, Takayoshi
    Kato, Jun
    Mizuno, Takahito
    Miyake, Yoshio
    Teramachi, Hitomi
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2022, 8 (01)
  • [42] Cost-utility analysis of a brief pain management programme and physical treatments for low back pain: Results from an economic analysis alongside a randomised clinical trial
    Whitehurst, D. G. T.
    Hay, E. M.
    Lewis, M.
    Raftery, J. P.
    Bryan, S.
    Yao, G. L.
    Mullis, R.
    RHEUMATOLOGY, 2006, 45 : I123 - I123
  • [43] Analysis of the costs of bevacizumab plus cisplatin and gemcitabine versus cetuximab plus vinorelbine and cisplatin in patients with advanced non-small cell lung cancer (NSCLC) in France: Results from a cost modelling study
    Chouaid, C.
    Vergnenegre, A.
    Florentin, V.
    Walzer, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK
    Hollier-Hann, Georgia
    Curry, Alistair
    Onishchenko, Kateryna
    Akehurst, Ron
    Ahmed, Fayyaz
    Davies, Brendan
    Keyzor, Ian
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (01) : 113 - 123
  • [45] Cost-utility analysis in a UK setting of vasoactive drug treatments in acute bleeding oesophageal varices in cirrhotic patients - A discrete event simulation model
    Wechowski, J. G.
    Tetlow, A. P.
    McEwan, P.
    Woehl, A.
    Currie, C. J.
    VALUE IN HEALTH, 2006, 9 (06) : A190 - A190
  • [46] Hair analysis of more than 140 families with drug consuming parents. Comparison between hair results from adults and their children
    Pragst, Fritz
    Krumbiegel, Franziska
    Thurmann, Denise
    Westendorf, Lena
    Methling, Maximilian
    Niebel, Andre
    Hartwig, Sven
    FORENSIC SCIENCE INTERNATIONAL, 2019, 297 : 161 - 170
  • [47] Drug coverage decisions should consider more than costs, say health policy authors - Cost-effectiveness data, pharmacoeconomic analysis called for
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (10) : 931 - 931
  • [48] MOST PATIENTS WOULD BENEFIT FROM MOVING MORE QUICKLY TO IVF: RESULTS FROM A COST-EFFECTIVENESS ANALYSIS OF A LARGE RETROSPECTIVE COHORT.
    Karvir, H. V.
    Elashoff, M.
    Parfitt, D. -E.
    Copperman, A. B.
    Beim, P. Yurttas
    FERTILITY AND STERILITY, 2014, 102 (03) : E84 - E84
  • [49] THE BENEFITS OF BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BCG) VERSUS CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CVC) IN PATIENTS WITH ADVANCED OR RECURRENT NON-SMALL CELL LUNG CANCER (NSCLC) IN SWEDEN: RESULTS FROM A COST-EFFECTIVENESS ANALYSIS
    Nuijten, M. J.
    Holmberg, C.
    Walzer, S.
    VALUE IN HEALTH, 2009, 12 (07) : A272 - A272
  • [50] Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study
    Esposti, Luca Degli
    Didoni, Guido
    Simon, Teresa
    Buda, Stefano
    Sangiorgi, Diego
    Esposti, Ezio Degli
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 1 - 7
12345